海正药业(600267.SH)子公司浙江省医药工业有限公司100%股权转让公开挂牌

Core Viewpoint - The company, Haizheng Pharmaceutical (600267.SH), is publicly listing the 100% equity stake of its wholly-owned subsidiary, Zhejiang Pharmaceutical Industry Co., Ltd., for transfer through a property rights exchange [1] Group 1 - The assessed value of the 100% equity stake in the subsidiary is 392 million yuan, with a proposed public listing base price of 430 million yuan [1] - The company submitted the application for the equity transfer on November 10, 2025, to the Taizhou Property Rights Exchange [1] - The official listing period for the equity transfer is from November 11, 2025, to December 8, 2025 [1]